Replies to post #90513 on Biotech Values

[DewDiligence]

1Q10 Recothrom sales were $9.0M, -2% vs 4Q09. ZGEN blames wholesaler destocking, in part, for the QoQ decline:

http://finance.yahoo.com/news/ZymoGenetics-Reports-First-bw-2894335383.html?x=0&.v=1